共 50 条
- [41] Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus-expressed nucleocapsid protein for early nephropathia epidemica diagnosis CLINICAL AND DIAGNOSTIC VIROLOGY, 1998, 10 (01): : 83 - 90
- [43] Short report: isolation and partial characterization of a Puumala virus from a human case of nephropathia epidemica in France (vol 52, pg 577, 1995) AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (01): : 177 - 177
- [46] Rosuvastatin as a Supplemental Treatment for the Clinical Symptoms of Nephropathia Epidemica: A Pilot Clinical Study VIRUSES-BASEL, 2024, 16 (02):
- [47] A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004 EPIDEMIOLOGY AND INFECTION, 2006, 134 (06): : 1333 - 1344
- [48] DETECTION OF HEMAGGLUTINATION-INHIBITING ANTIBODIES IN PATIENTS WITH NEPHROPATHIA EPIDEMICA AND KOREAN HEMORRHAGIC-FEVER BY USING PUUMALA VIRUS-CELL CULTURE ANTIGEN JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (05): : 997 - 998
- [49] High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 957 - 963
- [50] Detection and Genetic Characterization of Puumala Orthohantavirus S-Segment in Areas of France Non-Endemic for Nephropathia Epidemica PATHOGENS, 2020, 9 (09): : 1 - 17